Efficient Scale-Up Of Monoclonal Antibody Production: From Bench Top To 500L

Monoclonal antibodies (mAbs) are a fast-growing class of therapeutics, making the ability to efficiently scale up production critical for biopharmaceutical companies. In this on-demand webinar, explore a successful case study for the scale-up of a Herceptin production process from a 3L benchtop to a 500L commercial-scale single-use bioreactor. The presentation will detail how consistent productivity was maintained and product quality was preserved across scales, while the downstream process remained straightforward.

Watch this webinar to learn how a well-integrated upstream process can simplify operations and help you meet the growing demand for high-quality biologics.